UCB SA
UCB SA (UCBJY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for UCB SA (UCBJY), covering cash flow, earnings, and balance sheets.
UCB SA (UCBJY) Income Statement & Financial Overview
View the income breakdown for UCB SA UCBJY across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $3.36B | $2.79B | $2.66B | $1.33B |
| Cost of Revenue | $1.02B | $851.00M | $1.009B | $452.50M |
| Gross Profit | $2.34B | $1.94B | $1.65B | $879.00M |
| Gross Profit Ratio | $0.70 | $0.70 | $0.62 | $0.66 |
| R&D Expenses | $992.00M | $789.00M | $871.00M | $435.50M |
| SG&A Expenses | $1.17B | $1.07B | $863.00M | $483.50M |
| Operating Expenses | $1.84B | $1.62B | $1.48B | $826.00M |
| Total Costs & Expenses | -$2.86B | $2.47B | $2.49B | $1.28B |
| Interest Income | $24.00M | $15.00M | $31.00M | $33.00M |
| Interest Expense | $108.00M | $92.00M | $115.00M | $0.00 |
| Depreciation & Amortization | $323.00M | $318.00M | $376.00M | $188.00M |
| EBITDA | $1.35B | $644.00M | $552.00M | $270.50M |
| EBITDA Ratio | $0.40 | $0.23 | $0.21 | $0.20 |
| Operating Income | $501.00M | $323.00M | $176.00M | $82.50M |
| Operating Income Ratio | $0.15 | $0.12 | $0.07 | $0.06 |
| Other Income/Expenses (Net) | $416.00M | -$77.00M | -$156.00M | -$42.00M |
| Income Before Tax | $917.00M | $246.00M | $40.00M | $20.00M |
| Income Before Tax Ratio | $0.27 | $0.09 | $0.02 | $0.02 |
| Income Tax Expense | $60.00M | $38.00M | $8.00M | $4.00M |
| Net Income | $857.00M | $208.00M | $32.00M | $16.00M |
| Net Income Ratio | $0.25 | $0.07 | $0.01 | $0.01 |
| EPS | $4.51 | $1.10 | $0.17 | $0.08 |
| Diluted EPS | $4.41 | $1.07 | $0.16 | $0.08 |
| Weighted Avg Shares Outstanding | $190.01M | $189.89M | $189.78M | $195.99M |
| Weighted Avg Shares Outstanding (Diluted) | $194.44M | $195.007M | $199.62M | $195.63M |
Over the last four quarters, UCB SA achieved steady financial progress, growing revenue from $1.33B in Q3 2023 to $3.36B in Q4 2024. Gross profit stayed firm with margins at 70% in Q4 2024 versus 66% in Q3 2023. Operating income totaled $501.00M in Q4 2024, maintaining a 15% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $1.35B. Net income rose to $857.00M, with EPS at $4.51. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan